Cancer diagnostics business, Pacific Edge to dual list on ASX
AUCKLAND, NEW ZEALAND: Cancer diagnostics business, Pacific Edge Limited (PEB) will lodge an application with the Australian Stock Exchange (ASX) to dual list as a Foreign Exempt Entity. Subject to the ASX accepting the application, PEB expects to be dual-listed…